Home › Funds › Context Capital Management, LLC › ARWR

Context Capital Management, LLC position in ARWR

ARROWHEAD PHARMACEUTICALS IN · Health Care

Context Capital Management, LLC reported holding 18,400,000 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN) in its Q2 2026 13F filing — a position valued at US$22.0M, representing 0.64% of its reported portfolio and ranking #41 among its reported holdings. Context Capital Management, LLC has disclosed ARWR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)18.40M sh
Reported value held$22.03M
Portfolio Weight0.64%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Context Capital Management, LLC's ARWR position evolved

Context Capital Management, LLC first disclosed a stake in ARWR in Q1 2026 at 14,900,000 shares (US$15.5M). The position peaked in Q2 2026 at 18,400,000 shares, worth US$22.0M. Across 2 filings, Context Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 18,400,000 shares valued at US$22.0M — an increase of 3,500,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 14.90M $15.45M New
Q2 2026 18.40M $22.03M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ARWR and 13F data

ARWR (ARROWHEAD PHARMACEUTICALS IN) is a Health Care company. 53 other funds we track also report a position in ARWR — the largest reported positions include Avoro Capital Advisors LLC (US$925.6M), FRED ALGER MANAGEMENT, LLC (US$269.1M), BAKER BROS. ADVISORS LP (US$162.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARWR

All ARWR fund holders →

FAQ

How long has Context Capital Management, LLC held ARWR?

Context Capital Management, LLC has disclosed ARWR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Context Capital Management, LLC's current position in ARWR?

As of Q2 2026, Context Capital Management, LLC holds 18.40M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), valued at $22.03M, representing 0.64% of its reported portfolio and ranking #41.

Has Context Capital Management, LLC been buying or selling ARWR?

In the latest 13F filing (Q2 2026), Context Capital Management, LLC increased its position in ARWR. The position peaked in Q2 2026 at 18.40M shares.

Which other funds hold ARWR?

Other major institutional holders of ARWR include Avoro Capital Advisors LLC, FRED ALGER MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.